mRNA Extraction and Purification Market Latest Q4 2023 Updated Report with Forecast to 2031

In This Article:

InsightAce Analytic Pvt. LTd.
InsightAce Analytic Pvt. LTd.

Companies covered in this report are Qiagen, Thermo Fisher Scientific, Promega Corporation, Agilent Technologies, Inc, Merck Kgaa, Miltenyi Biotec , Biobasic Inc, Takara Bio, Inc, New England Biolabs, Omega Bio-Tek, Inc, Norgen Biotek, Zymo Research, F. Hoffmann-La Roche Ag, Genaxxon Bioscience Gmbh, Biovision, Analytik Jena Ag

Jersey City, NJ, Nov. 15, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global mRNA Extraction and Purification Market- By Product (Kits/Reagents, Instruments) End-user (Academics and Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Other End Users) Trends, Industry Competition Analysis, Revenue and Forecast To 2030."

According to company's newest research, The mRNA Extraction and Purification Market Size is valued at USD 826.0 Million in 2022 and is predicted to reach USD 3972.2 Million by the year 2031 at a 19.6% CAGR during the forecast period for 2023-2031.

Many downstream experiments rely on high-quality RNA molecules, including cloning, reverse transcription for cDNA synthesis, RT-PCR, RT-qPCR, and RNA-seq. RNA purification methods include phenol-chloroform extraction, spin-column purification, and magnetic beads. Among these, the magnetic beads method is popular for extracting specific mRNA. The beads make use of the poly-A tail on mRNA, which distinguishes it from other RNA. This is especially useful for separating it from rRNA, which is much more abundant. Extraction and purification processes employ a variety of reagents, including enzymes and buffers containing chaotropic agents such as guanidinium isothiocyanate, and sodium dodecyl sulphate (SDS), Sarcosyl, guanidinium chloride, urea, phenol or chloroform. mRNA is used in research to determine which proteins are being translated and how much transcript is being produced by the cell. Synthetic mRNA production necessitates a purification step to extract the final mRNA product from the solution in which it was transcribed.


Free PDF Report Brochure @ https://www.insightaceanalytic.com/request-sample/1285


The need for diagnostic tools and other critical care medical devices has grown dramatically over the past two years as a result of the coronavirus' rapid outbreak. Rapid diagnostic testing of COVID-19 infection boosts drug development and testing facilities worldwide. Pharmaceutical development accelerates research to develop breakthrough molecules to meet the growing needs of drug development. The government provides capital investments in institutes and laboratories for Research and Development Activities to Improve Growth Prospects. The drug developers prefer mRNA-based cancer treatments, reflecting in the mRNA therapeutics market valuation. This triggers the RNA extraction and purification services and research on nucleic acids. Rising funding initiatives for biotechnology research, significant life sciences research, an increasing patient population, and supporting government activities are among the reasons fueling the market's expansion.